I held variety of global senior clinical scientific roles over 15 years at Smith & Nephew Advanced Wound Management. I joined in 2002. Working in large multi-disciplinary global teams designing, launching and marketing medical devices such as: VERSAJET™ hydrosurgery debridement system, BIOBRANE™ temporary biosynthetic skin replacement, and negative pressure wound therapy (NPWT) systems such as RENASYS™ and PICO™ and building clinical evidence to support their use.  See the papers I co-authored on the Publications pages.  

Prior to joining industry, I led a team of scientists and surgeons at the Blond McIndoe Research centre at the Queen Victoria Hospital in East Grinstead (1994 to 2002) home of the famous Burn Unit that had treated injured airman "the Guinea Pigs" during WWII .  As well as studies on burns and plastic surgery our work was centred on the concept of using laboratory cell culture to expand a small biopsy into a larger quantity of tissue; either for grafting back to the same patient or using it as a donor for an unrelated patient.  Of special interest to us were techniques to track and mark cells so that it was possible to say something about their contribution to the reconstructed tissue and wound healing.  See the papers we published on skin and corneal epithelial and chondrocyte transfer in the Publications pages.

Before I embarked on a career in wound healing and reconstructive surgery, I worked in a completely different field.  This was the study of the rates at which cells make errors when they copy or express their genes - as mutations when they copy their DNA and as errors when they translate messenger RNA into proteins.  If you can make a cell make a mistake when it arrives at a mutation - it could be a case of "two wrongs make a right" and the effects of the mutation can be reduced or "suppressed".  In the years since I left this area some human therapies have been developed using the fundamental knowledge and understanding of  how cells translate their genes into protein and how they control the fidelity at which they do this. See My publications 2